» Articles » PMID: 37101044

[Mental Disorders and Diabetes Mellitus (Update 2023)]

Overview
Publisher Springer
Specialty General Medicine
Date 2023 Apr 26
PMID 37101044
Authors
Affiliations
Soon will be listed here.
Abstract

Psychiatric disorders and psychological problems are common in patients with diabetes mellitus. There is a twofold increase in depression which is associated with suboptimal glycemic control and increased morbidity and mortality. Other psychiatric disorders with a higher incidence of diabetes are cognitive impairment, dementia, disturbed eating behavior, anxiety disorders, schizophrenia, bipolar disorders and borderline personality disorder. The coincidence of mental disorders and diabetes has unfavorable influences on metabolic control and micro- and macroangiopathic complications. Improvement of therapeutic outcome is a challenge in the modern health care system. The intentions behind this position paper are to rise awareness of this special set of problems, to intensify cooperation between involved health care providers and to reduce incidence of diabetes mellitus as well as morbidity and mortality from diabetes in this patient group.

Citing Articles

Metabolic Dysfunctions, Dysregulation of the Autonomic Nervous System, and Echocardiographic Parameters in Borderline Personality Disorder: A Narrative Review.

Bozzatello P, Marin G, Gabriele G, Brasso C, Rocca P, Bellino S Int J Mol Sci. 2024; 25(22).

PMID: 39596351 PMC: 11594816. DOI: 10.3390/ijms252212286.


Healthcare and health situation of adults with type 2 diabetes in Germany: The study GEDA 2021/2022-Diabetes.

Heidemann C, Du Y, Mauz E, Walther L, Peitz D, Muller A J Health Monit. 2024; 9(2):e12128.

PMID: 39081469 PMC: 11262738. DOI: 10.25646/12128.

References
1.
Young-Hyman D, De Groot M, Hill-Briggs F, Gonzalez J, Hood K, Peyrot M . Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016; 39(12):2126-2140. PMC: 5127231. DOI: 10.2337/dc16-2053. View

2.
De Hert M, Dobbelaere M, Sheridan E, Cohen D, Correll C . Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry. 2011; 26(3):144-58. DOI: 10.1016/j.eurpsy.2010.09.011. View

3.
Smith M, Hopkins D, Peveler R, Holt R, Woodward M, Ismail K . First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2008; 192(6):406-11. DOI: 10.1192/bjp.bp.107.037184. View

4.
De Hert M, Dekker J, Wood D, Kahl K, Holt R, Moller H . Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of.... Eur Psychiatry. 2009; 24(6):412-24. DOI: 10.1016/j.eurpsy.2009.01.005. View

5.
Fisher L, Hessler D, Polonsky W, Mullan J . When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012; 35(2):259-64. PMC: 3263871. DOI: 10.2337/dc11-1572. View